, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 13

Publication Record


Nonconventional Therapeutics against .
Grunenwald CM, Bennett MR, Skaar EP
(2018) Microbiol Spectr 6:
MeSH Terms: Anti-Bacterial Agents, Antibodies, Bacterial, Bacteriophages, Biofilms, Drug Discovery, Drug Resistance, Multiple, Bacterial, Humans, Phage Therapy, Photochemotherapy, Quorum Sensing, Staphylococcal Infections, Staphylococcus aureus, Virulence, Virulence Factors
Show Abstract · Added April 7, 2019
is one of the most important human pathogens that is responsible for a variety of diseases ranging from skin and soft tissue infections to endocarditis and sepsis. In recent decades, the treatment of staphylococcal infections has become increasingly difficult as the prevalence of multi-drug resistant strains continues to rise. With increasing mortality rates and medical costs associated with drug resistant strains, there is an urgent need for alternative therapeutic options. Many innovative strategies for alternative drug development are being pursued, including disruption of biofilms, inhibition of virulence factor production, bacteriophage-derived antimicrobials, anti-staphylococcal vaccines, and light-based therapies. While many compounds and methods still need further study to determine their feasibility, some are quickly approaching clinical application and may be available in the near future.
0 Communities
1 Members
0 Resources
MeSH Terms
Magnetic Extraction of Acinetobacter baumannii Using Colistin-Functionalized γ-FeO/Au Core/Shell Composite Nanoclusters.
Bell CS, Mejías R, Miller SE, Greer JM, McClain MS, Cover TL, Giorgio TD
(2017) ACS Appl Mater Interfaces 9: 26719-26730
MeSH Terms: Acinetobacter Infections, Acinetobacter baumannii, Anti-Bacterial Agents, Colistin, Drug Resistance, Multiple, Bacterial, Ferric Compounds, Humans, Microbial Sensitivity Tests
Show Abstract · Added March 21, 2018
Acinetobacter baumannii is a Gram-negative bacterium of increasing concern due to its virulence and persistence in combat and healthcare environments. The incidence of both community-acquired and nosocomial A. baumannii infections is on the rise in foreign and domestic healthcare facilities. Treatment options are limited due to the acquisition of multidrug resistance to the few effective antibiotics. Currently, the most effective pharmaceutically based treatment for multidrug-resistant A. baumannii infections is the antibiotic colistin (polymyxin E). To minimize side effects associated with administration of colistin or other toxic antimicrobial agents, we propose the development of a nanotechnology-mediated treatment strategy. In this design-based effort, colistin-functionalized multilayered, inorganic, magnetoplasmonic nanoconstructs were fabricated to bind to the surface of A. baumannii. This result, for the first time, demonstrates a robust, pharmaceutical-based motif for high affinity, composite nanoparticulates targeting the A. baumannii surface. The antibiotic-activated nanomaterials demonstrated cytocompatibility with human cells and no acute bacterial toxicity at nanoparticle to bacterial concentrations <10 000:1. The magnetomotive characteristics of the nanomaterial enabled magnetic extraction of the bacteria. In a macroscale environment, maximal separation efficiencies exceeding 38% were achieved. This result demonstrates the potential for implementation of this technology into micro- or mesofluidic-based separation environments to enhance extraction efficiencies. The future development of such a mesofluidic-based, nanotechnology-mediated platform is potentially suitable for adjuvant therapies to assist in the treatment of sepsis.
0 Communities
1 Members
0 Resources
8 MeSH Terms
Staphylococcus aureus Infection of Human Gestational Membranes Induces Bacterial Biofilm Formation and Host Production of Cytokines.
Doster RS, Kirk LA, Tetz LM, Rogers LM, Aronoff DM, Gaddy JA
(2017) J Infect Dis 215: 653-657
MeSH Terms: Biofilms, Chorioamnionitis, Cytokines, Drug Resistance, Multiple, Bacterial, Female, Humans, Infant, Newborn, Placenta, Pregnancy, Pregnancy Complications, Infectious, Premature Birth, Staphylococcal Infections, Staphylococcus aureus
Show Abstract · Added April 26, 2017
Staphylococcus aureus, a metabolically flexible gram-positive pathogen, causes infections in a variety of tissues. Recent evidence implicates S. aureus as an emerging cause of chorioamnionitis and premature rupture of membranes, which are associated with preterm birth and neonatal disease. We demonstrate here that S. aureus infects and forms biofilms on the choriodecidual surface of explanted human gestational membranes. Concomitantly, S. aureus elicits the production of proinflammatory cytokines, which could ultimately perturb maternal-fetal tolerance during pregnancy. Therefore, targeting the immunological response to S. aureus infection during pregnancy could attenuate disease among infected individuals, especially in the context of antibiotic resistance.
Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
0 Communities
2 Members
0 Resources
13 MeSH Terms
High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
Eilertson B, Maruri F, Blackman A, Herrera M, Samuels DC, Sterling TR
(2014) Antimicrob Agents Chemother 58: 3270-5
MeSH Terms: Anti-Bacterial Agents, DNA Gyrase, DNA, Bacterial, Drug Resistance, Multiple, Bacterial, Fluoroquinolones, Mutation, Mycobacterium tuberculosis, Phenotype, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary
Show Abstract · Added May 27, 2014
Heteroresistance is the coexistence of populations with differing nucleotides at a drug resistance locus within a sample of organisms. Although Sanger sequencing is the gold standard for sequencing, it may be less sensitive than deep sequencing for detecting fluoroquinolone heteroresistance in Mycobacterium tuberculosis. Twenty-seven fluoroquinolone monoresistant and 11 fluoroquinolone-susceptible M. tuberculosis isolates were analyzed by Sanger and Illumina deep sequencing. Individual sequencing reads were analyzed to detect heteroresistance in the gyrA and gyrB genes. Heteroresistance to fluoroquinolones was identified in 10/26 (38%) phenotypically fluoroquinolone-resistant samples and 0/11 (P = 0.02) fluoroquinolone-susceptible controls. One resistant sample was excluded because of contamination with the laboratory strain M. tuberculosis H37Rv. Sanger sequencing revealed resistance-conferring mutations in 15 isolates, while deep sequencing revealed mutations in 20 isolates. Isolates with fluoroquinolone resistance-conferring mutations by Sanger sequencing all had at least those same mutations identified by deep sequencing. By deep sequencing, 10 isolates had a single fixed (defined as >95% frequency) mutation, while 10 were heteroresistant, 5 of which had a single unfixed (defined as <95% frequency) mutation and 5 had multiple unfixed mutations. Illumina deep sequencing identified a higher proportion of fluoroquinolone-resistant M. tuberculosis isolates with heteroresistance than did Sanger sequencing. The heteroresistant isolates frequently demonstrated multiple mutations, but resistant isolates with fixed mutations each had only a single mutation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
0 Communities
2 Members
0 Resources
10 MeSH Terms
Recent advances in experimental models of osteomyelitis.
Cassat JE, Skaar EP
(2013) Expert Rev Anti Infect Ther 11: 1263-5
MeSH Terms: Adult, Animals, Anti-Bacterial Agents, Biofilms, Bone and Bones, Child, Disease Models, Animal, Drug Delivery Systems, Drug Resistance, Multiple, Bacterial, Humans, Osteomyelitis, Rabbits, Rats, Staphylococcal Infections, Staphylococcus aureus
Added January 20, 2015
0 Communities
2 Members
0 Resources
15 MeSH Terms
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Makobongo MO, Einck L, Peek RM, Merrell DS
(2013) PLoS One 8: e68917
MeSH Terms: Adamantane, Amoxicillin, Antitubercular Agents, Cell Membrane, Chloramphenicol, Clarithromycin, Drug Resistance, Multiple, Bacterial, Drug Synergism, Duodenal Ulcer, Duodenitis, Ethylenediamines, Gastritis, Helicobacter Infections, Helicobacter pylori, Humans, Hydrogen-Ion Concentration, Metronidazole, Microbial Sensitivity Tests, Microscopy, Electron, Stomach Ulcer
Show Abstract · Added September 3, 2013
The most evident challenge to treatment of Helicobacter pylori, a bacterium responsible for gastritis, peptic ulcers and gastric cancer, is the increasing rate of resistance to all currently used therapeutic antibiotics. Thus, the development of novel therapies is urgently required. N-geranyl-N'-(2-adamantyl) ethane-1, 2-diamine (SQ109) is an ethylene diamine-based antitubercular drug that is currently in clinical trials for the treatment of tuberculosis (TB). Previous pharmacokinetic studies of SQ109 revealed that persistently high concentrations of SQ109 remain in the stomach 4 hours post oral administration in rats. This finding, combined with the need for new anti-Helicobacter therapies, prompted us to define the in vitro efficacy of SQ109 against H. pylori. Liquid broth micro-dilution was used for susceptibility studies to determine the antimicrobial activity of SQ109 against a total of 6 laboratory strains and 20 clinical isolates of H. pylori; the clinical isolates included a multi-drug resistant strain. All strains tested were susceptible to SQ109 with MIC and MBC ranges of 6-10 µM and 50-60 µM, respectively. SQ109 killing kinetics were concentration- and time-dependent. SQ109 killed H. pylori in 8-10 h at 140 µM (2MBCs) or 4-6 h at 200 µM (~3MBCs). Importantly, though the kinetics of killing were altered, SQ109 retained potent bactericidal activity against H. pylori at low pH. Additionally, SQ109 demonstrated robust thermal stability and was effective at killing slow growing or static bacteria. In fact, pretreatment of cultures with a bacteriostatic concentration of chloramphenicol (Cm) synergized the effects of typically bacteriostatic concentrations of SQ109 to the level of five-logs of bacterial killing. A molar-to-molar comparison of the efficacy of SQ109 as compared to metronidazole (MTZ), amoxicillin (AMX), rifampicin (RIF) and clarithromycin (CLR), revealed that SQ109 was superior to MTZ, AMX and RIF but not to CLR. Finally, the frequency of resistance to SQ109 was low and electron microscopy studies revealed that SQ109 interacted with bacterial inner membrane and cytoplasmic content(s). Collectively, our in vitro data demonstrate that SQ109 is an effective monotherapy against susceptible and multi-drug resistant strains of H. pylori and may be useful alone or in combination with other antibiotics for development as a new class of anti-Helicobacter drugs.
0 Communities
2 Members
0 Resources
20 MeSH Terms
Atropisomeric dihydroanthracenones as inhibitors of multiresistant Staphylococcus aureus.
Bara R, Zerfass I, Aly AH, Goldbach-Gecke H, Raghavan V, Sass P, Mándi A, Wray V, Polavarapu PL, Pretsch A, Lin W, Kurtán T, Debbab A, Brötz-Oesterhelt H, Proksch P
(2013) J Med Chem 56: 3257-72
MeSH Terms: Aloe, Animals, Anthracenes, Anti-Bacterial Agents, BALB 3T3 Cells, Cell Line, Tumor, DNA, Bacterial, Drug Resistance, Multiple, Bacterial, Endophytes, Eurotiales, Humans, Mice, Microbial Sensitivity Tests, Nuclear Magnetic Resonance, Biomolecular, SOS Response, Genetics, Staphylococcus aureus, Stereoisomerism
Show Abstract · Added February 12, 2015
Two bisdihydroanthracenone atropodiastereomeric pairs, including homodimeric flavomannin A (1) and the previously unreported flavomannin B (2), two new unsymmetrical dimers (3 and 4), and two new mixed dihydroanthracenone/anthraquinone dimers (5 and 6) were isolated from Talaromyces wortmannii , an endophyte of Aloe vera . The structures of 2-6 were elucidated by extensive NMR and mass spectrometric analyses. The axial chirality of the biaryls was determined using TDDFT ECD and VCD calculations, the combination of which however did not allow the assignment of the central chirality elements of 1. The compounds exhibited antibacterial activity against Staphylococcus aureus , including (multi)drug-resistant clinical isolates. Reporter gene analyses indicated induction of the SOS response for some of the derivatives, suggesting interference with DNA structure or metabolism. Fluorescence microscopy demonstrated defective segregation of the bacterial chromosome and DNA degradation. Notably, the compounds showed no cytotoxic activity, encouraging their further evaluation as potential starting points for antibacterial drug development.
0 Communities
1 Members
0 Resources
17 MeSH Terms
Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration.
Hood MI, Mortensen BL, Moore JL, Zhang Y, Kehl-Fie TE, Sugitani N, Chazin WJ, Caprioli RM, Skaar EP
(2012) PLoS Pathog 8: e1003068
MeSH Terms: Acinetobacter Infections, Acinetobacter baumannii, Animals, Biological Transport, Active, Carbapenems, Disease Models, Animal, Drug Resistance, Multiple, Bacterial, Humans, Leukocyte L1 Antigen Complex, Lung, Manganese, Mice, Mice, Knockout, Neutrophil Infiltration, Neutrophils, Pneumonia, Bacterial, Zinc
Show Abstract · Added March 7, 2014
Acinetobacter baumannii is an important nosocomial pathogen that accounts for up to 20 percent of infections in intensive care units worldwide. Furthermore, A. baumannii strains have emerged that are resistant to all available antimicrobials. These facts highlight the dire need for new therapeutic strategies to combat this growing public health threat. Given the critical role for transition metals at the pathogen-host interface, interrogating the role for these metals in A. baumannii physiology and pathogenesis could elucidate novel therapeutic strategies. Toward this end, the role for calprotectin- (CP)-mediated chelation of manganese (Mn) and zinc (Zn) in defense against A. baumannii was investigated. These experiments revealed that CP inhibits A. baumannii growth in vitro through chelation of Mn and Zn. Consistent with these in vitro data, Imaging Mass Spectrometry revealed that CP accompanies neutrophil recruitment to the lung and accumulates at foci of infection in a murine model of A. baumannii pneumonia. CP contributes to host survival and control of bacterial replication in the lung and limits dissemination to secondary sites. Using CP as a probe identified an A. baumannii Zn acquisition system that contributes to Zn uptake, enabling this organism to resist CP-mediated metal chelation, which enhances pathogenesis. Moreover, evidence is provided that Zn uptake across the outer membrane is an energy-dependent process in A. baumannii. Finally, it is shown that Zn limitation reverses carbapenem resistance in multidrug resistant A. baumannii underscoring the clinical relevance of these findings. Taken together, these data establish Zn acquisition systems as viable therapeutic targets to combat multidrug resistant A. baumannii infections.
1 Communities
3 Members
0 Resources
17 MeSH Terms
genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.
Hood MI, Becker KW, Roux CM, Dunman PM, Skaar EP
(2013) Infect Immun 81: 542-51
MeSH Terms: Acinetobacter Infections, Acinetobacter baumannii, Animals, Anti-Bacterial Agents, Antimicrobial Cationic Peptides, Bacterial Proteins, Colistin, Drug Resistance, Multiple, Bacterial, Female, Glycosyltransferases, Immune Tolerance, Immunity, Innate, Lipopolysaccharides, Lung, Mannosyltransferases, Mice, Mice, Inbred C57BL, Molecular Sequence Data, Mutation, Pneumonia
Show Abstract · Added February 11, 2016
Acinetobacter baumannii is a leading cause of multidrug-resistant infections worldwide. This organism poses a particular challenge due to its ability to acquire resistance to new antibiotics through adaptation or mutation. This study was undertaken to determine the mechanisms governing the adaptability of A. baumannii to the antibiotic colistin. Screening of a transposon mutant library identified over 30 genes involved in inducible colistin resistance in A. baumannii. One of the genes identified was lpsB, which encodes a glycosyltransferase involved in lipopolysaccharide (LPS) synthesis. We demonstrate that loss of LpsB function results in increased sensitivity to both colistin and cationic antimicrobial peptides of the innate immune system. Moreover, LpsB is critical for pathogenesis in a pulmonary model of infection. Taken together, these data define bacterial processes required for intrinsic colistin tolerance in A. baumannii and underscore the importance of outer membrane structure in both antibiotic resistance and the pathogenesis of A. baumannii.
0 Communities
1 Members
0 Resources
20 MeSH Terms
Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death.
van der Heijden YF, Maruri F, Blackman A, Holt E, Warkentin JV, Shepherd BE, Sterling TR
(2012) Int J Tuberc Lung Dis 16: 1162-7
MeSH Terms: Adult, Age Factors, Aged, Anti-Bacterial Agents, Antitubercular Agents, Coinfection, Drug Resistance, Multiple, Bacterial, Female, Fluoroquinolones, HIV Infections, Humans, Kaplan-Meier Estimate, Logistic Models, Male, Middle Aged, Multivariate Analysis, Mycobacterium tuberculosis, Odds Ratio, Prospective Studies, Risk Assessment, Risk Factors, Sputum, Tennessee, Time Factors, Treatment Outcome, Tuberculosis, Pulmonary
Show Abstract · Added May 29, 2014
SETTING - Fluoroquinolone (FQ) exposure before tuberculosis (TB) diagnosis is common, but its effect on outcomes, including mortality, is unclear.
DESIGN - Among TB patients reported to the Tennessee Department of Health from 2007 to 2009, we assessed FQ exposure within 6 months before TB diagnosis. The primary outcome was the combined endpoint of death at the time of TB diagnosis and during anti-tuberculosis treatment.
RESULTS - Among 609 TB cases, 214 (35%) received FQs within 6 months before TB diagnosis. A total of 71 (12%) persons died; 10 (2%) were dead at TB diagnosis and 61 (10%) died during anti-tuberculosis treatment. In multivariable logistic regression analysis, factors independently associated with death were older age (OR 1.05 per year, 95%CI 1.04-1.07), human immunodeficiency virus infection (OR 8.08, 95%CI 3.83-17.06), US birth (OR 3.03, 95%CI 1.03-9.09), and any FQ exposure before TB diagnosis (OR 1.82, 95%CI 1.05-3.15). Persons with FQ exposure before TB diagnosis were more likely to have culture- and smear-positive disease than unexposed persons.
CONCLUSIONS - Among this patient population, FQ exposure before TB diagnosis was associated with an increased risk of death. These findings underscore the need for cautious use of FQs in persons with possible TB.
0 Communities
1 Members
0 Resources
26 MeSH Terms